O carcinoma espinocelular de esôfago (CEC) é um tipo de carcinoma de esôfago (CE) que pode afetar qualquer parte do esôfago, mas geralmente está localizado no terço superior ou médio.
Introdução
O que você precisa saber de cara
O carcinoma de células escamosas esofágicas é um tipo de tumor maligno que afeta as paredes do esôfago, geralmente em sua parte média ou superior. Os pacientes costumam sentir dor torácica, tosse, alterações na voz e episódios de náuseas ou vômitos. Por ter origem multifatorial, a doença costuma se manifestar na idade adulta ou em pessoas idosas. No Brasil, o SUS oferece suporte por meio do PCDT de Carcinoma de Esôfago, no qual o tratamento é conduzido conforme a autonomia da equipe médica de cada serviço credenciado.
O carcinoma espinocelular de esôfago (CEC) é um tipo de carcinoma de esôfago (CE) que pode afetar qualquer parte do esôfago, mas geralmente está localizado no terço superior ou médio.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 2 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 8 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
4 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.
Esophageal cancer
A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.
Hereditary non-polyposis colorectal cancer 6
An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Medicamentos aprovados (FDA)
2 medicamentos encontrados nos registros da FDA americana.
Variantes genéticas (ClinVar)
991 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
14 vias biológicas associadas aos genes desta condição.
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Carcinoma de células escamosas esofágicas
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 37 países. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
100 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
Publicações mais relevantes
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.
Recent research has demonstrated the importance of the tumor microenvironment (TME) in the behavior of solid tumors. Numerous discoveries suggest that tumor progression in a variety of malignancies, including those of the gastrointestinal tract, may be predicted by pathological evaluation of the desmoplastic reaction (DR), tumor budding (TB) and tumor-infiltrating lymphocytes (TIL). While some studies have demonstrated the prognostic impact of TIL in patients with squamous cell carcinoma of the esophagus (ESCC), the data have not reached agreement. Furthermore, few studies have investigated the relationship of DR and TB with disease progression. The relationships between DR, TB and TIL in these tumors remain to be investigated. Therefore, this study was undertaken to explore the relationships between DR, TB and TIL and histopathological parameters related to tumor behavior and assess their prognostic role in predicting survival in patients with ESCC. The retrospective case series included 98 patients diagnosed with ESCC. DR was assessed on the basis of the maturation of the tumor stroma. TB was evaluated according to the International Tumor Budding Conference (ITBCC) criteria. A semiquantitative method with a 5% threshold value was used to evaluate TIL. A significant correlation was identified between DR and sex (p = 0.023) and between DR and depth of invasion (T) (p = 0.006). TB and TIL were correlated with T (p < 0.001 and p = 0.002), lymph node metastasis (LNM) (p = 0.006 and p = 0.018), tumor stage (p < 0.001) and p = 0.003). Although DR was significantly positively correlated with TB (p < 0.001), no correlation was detected with TIL. A negative correlation between TIL and TB was also observed (p = 0.04). The results of the univariate analysis revealed significant correlations between poor survival rates and T (p < 0.001), LNM (p = 0.002), stage (p < 0.001), DR (p < 0.001), TB (p < 0.001), and TIL (p = 0.009). The multivariate analysis revealed that DR (p < 0.001), TB (p < 0.001), and T (p < 0.001) were independent prognostic factors. Our study emphasized that the assessment of DR and TB can be used to categorize individuals with ESCC for therapy and prognosis. Further research is needed to clarify the prognostic roles of TIL and their subtypes in ESCC and how they are associated with DR, depending on their association with TB.
Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy.
In the Western hemisphere, nonmetastatic locally advanced esophageal carcinoma is mostly treated in multimodal therapy protocols according to current therapy guidelines. In squamous cell carcinoma of the esophagus, neoadjuvant chemoradiation is the favorable option. Unimodal surgical and chemoradiation treatment alternatives show inferior results on this entity. For locally advanced adenocarcinoma of the esophagus perioperative chemotherapy and neoadjuvant chemoradiation have been competing treatment approaches in the recent past. Both are evidence based (class I evidence) and superior compared to unimodal surgery. However, the latest results of head-to-head comparative therapy studies show superior overall survival results for the FLOT regimen of perioperative chemotherapy. Furthermore, immunotherapy and targeted therapy with monoclonal antibodies have become a strong focus of current clinical research. Nivolumab as well as trastuzumab are already an important part of the current standard therapies. In both entities - SCC and AC - a significant quota of patients shows a locoregional complete remission of the tumor in the specimen after modern neoadjuvant therapy and surgical resection. The addition of immunotherapy and targeted therapy to neoadjuvant therapy further increases complete remission rates in defined subgroups according to the results of current studies. Currently, three prospective randomized trials are ongoing on the subject of future possibilities for organ-preserving concepts in case of complete clinical remission ("surgery as needed," "watch and wait"). It is to be expected for the future that curative short-term and long-term treatment results in locally advanced esophageal carcinoma will significantly improve, particularly due to the additional possibilities of immunotherapy and organ-preserving therapy concepts in postneoadjuvant complete remission.
APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.
Squamous cell carcinoma of the esophagus (ESCC) has poor prognosis after surgery and adjuvant chemotherapy. Biomarkers predicting treatment efficacy are urgently needed. This study investigated apurinic/apyrimidinic endonuclease 1 (APE1), a key DNA repair enzyme, as a prognostic biomarker in ESCC patients receiving postoperative chemotherapy. To assess the relationship between APE1 expression and survival outcomes post-adjuvant chemotherapy. 115 ESCC patients receiving surgery and platinum-based chemotherapy were retrospectively enrolled. APE1 expression (low, medium, high) was determined by immunohistochemistry (IHC). Furthermore, external validation was performed using a tissue microarray cohort of 110 post-chemotherapy ESCC patients and the GES5325 dataset. Survival was analyzed using Kaplan-Meier and Cox regression. The tumor immune microenvironment was characterized by multiplex immunofluorescence (mIF). High APE1 expression correlated significantly with advanced T stage (p=0.005) and neural invasion (p=0.036). The high-expression group had significantly worse 5-year OS (27% vs. 91.4%) and DFS (14.3% vs. 55.3%) than the low-expression group (p<0.001), confirmed in public databases. Multivariate analysis identified APE1 expression (DFS: HR=4.600, 95% CI 1.285-16.466; OS: HR=16.001, 95% CI 4.826-53.061) and clinical stage as independent prognostic factors. Additionally, external validation was carried out using tissue microarrays and the GEO database to confirm the reliability. mIF analysis revealed significantly increased infiltration of FOXP3+ regulatory T cells (Treg) and cancer-associated fibroblasts (CAFs) in the APE1-high group. High APE1 expression is an independent predictor of poor prognosis in ESCC patients receiving postoperative chemotherapy, associated with Treg and CAFs-mediated immunosuppression. APE1 serves as a prognostic biomarker linked to immunosuppression, enabling personalized adjuvant therapy.
Pharyngeal squamous cell carcinoma and risk of later esophageal squamous cell carcinoma - A nationwide population-based matched case-control study.
Pharyngeal squamous cell carcinoma has been linked to later squamous cell carcinoma of the esophagus, but it is unclear if risks are similar to that of Barrett's esophagus and would justify routine gastroscopy surveillance. Data on pharyngeal and esophageal cancers in 1980-2016 were retrieved through histopathology reports from Sweden's 28 pathology departments and linked to national population-based healthcare registers. We calculated hazard ratios (HRs) for esophageal cancer and death in patients with pharyngeal carcinoma compared to a matched general population, and in a secondary analysis also compared to siblings of patients. We identified 1055 adults with pharyngeal cancer without prior or concomitant cancer. 78 % were men and median age at diagnosis of pharyngeal cancer was 64 years. During a median follow-up of 2.5 years four (0.4 %) patients developed esophageal squamous cell carcinoma, equal to 1 in 263 patients (HR = 14.3; 95 % CI = 1.6-132.3). In a competing risk analysis, the risk estimate for ESCC dropped and did not attain statistical significance (subdistribution HR=1.9 (95 % CI=0.7-5.2)). Some 855 patients (81 %) died during follow-up, representing a 7.7-fold increased risk of death among patients with pharyngeal cancer (Cox regression: HR=7.7; 95 % CI = 6.8-8.6). The yearly risk of developing esophageal squamous cell carcinoma was 0.07 %. This is lower than in Barrett's esophagus and argues against long-term endoscopic surveillance among patients with pharyngeal cancer.
Clinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.
PurposeTo present a case of non-uveal intraocular metastatic disease originating from relapsed breast carcinoma.MethodsWe report a 67-year-old female with a history of HER2-positive breast carcinoma in remission and recent squamous cell carcinoma of the esophagus presenting with ocular symptoms. Comprehensive ophthalmic examinations and multimodal imaging were performed. Diagnostic procedures included diagnostic vitrectomy and cytology analysis.ResultsThe patient was found to have metastatic carcinoma to the vitreous and retina with an immunophenotype compatible with breast carcinoma. Neurological symptoms led to the discovery of metastatic brain lesions. The patient underwent palliative systemic treatment and stereotactic brain irradiation. Follow-up showed the progression of the ocular lesions.ConclusionThis case informs on the clinical and pathological findings of a rare non-uveal intraocular metastatic disease originating from relapsed breast carcinoma. Vitreous biopsy and multimodal imaging were required for a proper diagnosis and management and would serve as a reference for further cases.
Publicações recentes
Co-infection of cytomegalovirus and Epstein-Barr virus-induced pneumonitis following hepatitis B reactivation in an esophageal cancer patient: A case report.
APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.
Pharyngeal squamous cell carcinoma and risk of later esophageal squamous cell carcinoma - A nationwide population-based matched case-control study.
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.
Clinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.
📚 EuropePMC609 artigos no totalmostrando 198
APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.
Frontiers in immunologyPharyngeal squamous cell carcinoma and risk of later esophageal squamous cell carcinoma - A nationwide population-based matched case-control study.
Cancer epidemiologyThe prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.
BMC gastroenterologyClinicopathologic correlations and multimodal imaging of vitreoretinal metastasis from breast carcinoma.
European journal of ophthalmologyNeoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy.
Innovative surgical sciencesAssociations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study.
Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusA Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.
Cancer research communicationsTiming of Surgery and Postoperative Outcomes in Esophagectomy for Squamous Cell Carcinoma: A Prospective Study in North India.
Journal of gastrointestinal cancerRight Ventricular Extrinsic Compression Tamponade Caused by Dilation/Necrosis of a Coloplasty Performed for Esophageal Squamous Cell Carcinoma.
Indian journal of surgical oncologyExploring the clinicopathological characteristics of submucosal tumor-like esophageal squamous cell carcinoma and the diagnostic significance of endoscopic ultrasound: a comprehensive analysis.
European journal of gastroenterology & hepatologyCase Report: Esophageal squamous cell carcinoma in a 13-year-old boy with a history of esophageal atresia with tracheoesophageal fistula.
Frontiers in pediatrics[Neoadjuvant therapy of locally advanced squamous cell carcinoma of the esophagus : Radiochemotherapy vs. doublet or triplet chemotherapy alone].
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]Squamous Cell Carcinoma of the Esophagus in an Adolescent: A Case Report.
CureusPaclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial.
Oncology research and treatmentThe role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.
SurgeryTreatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem.
Scientific reportsPurulent Pericarditis as the First Manifestation of Esophageal Carcinoma.
Portuguese journal of cardiac thoracic and vascular surgeryLeiomyosarcoma of the esophagus, arising from lamina muscularis mucosae, in a combination with microinvasive squamous cell carcinoma-A case report.
Indian journal of pathology & microbiologyPembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation.
Expert opinion on drug safetyAtypical intrapapillary capillary loops in early-stage basaloid squamous cell carcinoma of the esophagus.
Revista espanola de enfermedades digestivasSimultaneous presentation and resection of esophageal cancer and metastasis to the pancreas: Α case report and literature review.
Molecular and clinical oncologyCarbon dioxide gas-induced pneumothorax versus one-lung ventilation in minimally invasive esophagectomy: a multicenter propensity score matching cohort study.
International journal of surgery (London, England)HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.
HeliyonTrends in Epidemiology of Esophageal Cancer in the US, 1975-2018.
JAMA network openRefractory Lactic Acidosis and Hypoglycemia in a Patient With Metastatic Esophageal Cancer Due to the Warburg Effect.
CureusMetachronous Squamous Cell Carcinoma of the Esophagus After Resolution of Previous Adenocarcinoma.
ACG case reports journalOPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus.
Cancer genomics & proteomicsRole of Confocal Laser Endomicroscopy in Early Detection of Upper Gastrointestinal Malignancy in High Risk Patients.
Asian Pacific journal of cancer prevention : APJCPIncreasing access to pathology services in low- and middle-income countries through innovative use of telepathology.
Surgical endoscopyA novel diagnostic signature of circulating tsRNAs and miRNAs in esophageal squamous cell carcinoma detected with a microfluidic platform.
Analytica chimica actaColloid gastric emptying with SPECT-CT after oesophagectomy.
JPMA. The Journal of the Pakistan Medical AssociationDOES NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER PATIENTS AFFECT POSTOPERATIVE OUTCOMES? A STUDY USING THE BECKER TUMOR REGRESSION GRADE SYSTEM AND LYMPH NODE REGRESSION.
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgeryTiming of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy.
Esophagus : official journal of the Japan Esophageal SocietyThe effect of Andrographis paniculata water extract on palliative management of metastatic esophageal squamous cell carcinoma-A phase II clinical trial.
Phytotherapy research : PTRA prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2.
BMC cancerChemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly.
Frontiers in oncologyDiffusely infiltrative squamous cell carcinoma of the esophagus resembling scirrhous gastric cancer: a case report.
Annals of medicine and surgery (2012)Long‑term prognosis and comprehensive endoscopic treatment strategy for esophageal cancer, including salvage endoscopic treatment after chemoradiation therapy.
Experimental and therapeutic medicineUpregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.
BMC cancerDefinitive radiation therapy with dose escalation is beneficial for patients with squamous cell cancer of the esophagus.
Journal of cancer research and therapeuticsIdentification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus.
Cellular and molecular gastroenterology and hepatologyAirway Management of a Patient With Tracheoesophageal Fistula and Tracheal Stent.
CureusA Case Report of Rare Synchronous Esophageal Malignancies With Dissimilar Histology: Squamous Cell Carcinoma and Small Cell Carcinoma.
CureusHub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Computational and mathematical methods in medicineSquamous Cell Carcinoma of the Esophagus.
Gastroenterology clinics of North AmericaEndoscopic stent placement after spontaneous esophageal perforation associated with chemoradiotherapy for esophageal cancer.
Revista espanola de enfermedades digestivasAdjuvant Chemotherapy for Pathological Node-Positive Disease in Squamous Cell Carcinoma of the Esophagus after Neoadjuvant Chemoradiotherapy Plus Surgery.
Journal of personalized medicineCommentary: Squamous cell carcinoma of the esophagus: Another target for checkpoint inhibition.
JTCVS openEndoscopic submucosal dissection for early esophageal squamous cell carcinoma with esophageal-gastric fundal varices caused by liver cirrhosis: a case report.
Translational cancer researchA diagnostic pitfall; Small cell carcinoma-like features in basaloid squamous cell carcinoma of the esophagus.
Histology and histopathologyeIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma.
Journal of translational medicineConstrictive pericarditis caused by pericardial metastasis from esophageal squamous cell carcinoma: a case report.
International cancer conference journalFirst-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.
Esophagus : official journal of the Japan Esophageal SocietyCutaneous metastasis from esophageal squamous cell carcinoma: A case report.
World journal of clinical casesEfficacy of thoracotomy and thoracoscopic-assisted esophageal surgery in conversion and salvage surgeries: a retrospective study.
World journal of surgical oncologyLiquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.
Frontiers in medicineA Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.
CancersTHE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY.
Arquivos de gastroenterologiaEsophageal carcinoma as a portal of entry for brainstem abscess formation.
Acta gastro-enterologica BelgicaLife Expectancy in Survivors of Esophageal Cancer Compared with the Background Population.
Annals of surgical oncologyMicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.
Cancer genomics & proteomicsUpdate on Management of Squamous Cell Esophageal Cancer.
Current oncology reportsSynchronous esophageal squamous cell carcinoma and hepatocellular carcinoma: A rare case report.
Radiology case reportsNEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE.
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgeryBayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
The Journal of thoracic and cardiovascular surgeryNeoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial.
Contemporary clinical trials communicationsClinico-epidemiological profile and treatment outcomes in patients with squamous cell carcinoma of the esophagus following docetaxel-based neoadjuvant chemotherapy: experience from a cancer care center in Northeast India.
Journal of the Egyptian National Cancer InstituteAtypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis.
Case reports in gastroenterologyA Rare Case of Esophageal Leukoplakia: A Potential Precursor to Esophageal Malignancy.
CureusDetection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear MedicineComparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus.
International journal of general medicineTreatment strategies and outcomes for elderly patients with locally advanced squamous cell carcinoma of the esophagus.
Surgery todayBulimia Nervosa Leading to Squamous Cell Carcinoma of the Esophagus in a Young Adult.
CureusEsophageal basaloid squamous cell carcinoma presenting as a subepithelial lesion.
Clinical journal of gastroenterologyEthiopian Medicinal Plants Traditionally Used for the Treatment of Cancer; Part 3: Selective Cytotoxic Activity of 22 Plants against Human Cancer Cell Lines.
Molecules (Basel, Switzerland)Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas.
Scientific reportsRole of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysis.
Thoracic cancerPrevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis.
Critical reviews in oncology/hematologyIntratumoral Metabolic Heterogeneity and Other Quantitative 18F-FDG PET/CT Parameters for Prognosis Prediction in Esophageal Cancer.
Radiology. Imaging cancerWhere to Start and What to Do Next: The Sequencing of Treatments in Metastatic Esophagogastric Cancer.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingTRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgeryPembrolizumab as a first-line therapy in spinocellular esophageal cancer.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnostiEsophageal Cancer: An Updated Review.
Southern medical journalBeyond Squamous Cell Carcinoma: Basaloid Squamous Cell Carcinoma of the Esophagus.
CureusPentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
Cancer imaging : the official publication of the International Cancer Imaging SocietyKissing tumors; the concurrent diagnosis of leiomyosarcoma and squamous cell carcinoma of the esophagus.
BMC surgeryA Pseudo-Infarction Pattern in the Setting of Esophageal Malignancy.
CureusHistological criteria for "intraepithelial squamous cell carcinoma" of the esophagus: continued dialogue between Ukrainian and Japanese pathologists.
Experimental oncologySalvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy.
Annals of surgical oncologyPalliative care for patients with esophageal cancer: a narrative review.
Annals of translational medicineIntramucosal squamous cell carcinoma of the esophagus: is surgery still an option?
EndoscopyThree-dimensional computed tomography image-oriented successful thoracoscopic subtotal esophagectomy for an esophageal cancer patient with an anomalous right superior pulmonary vein: A case report.
International journal of surgery case reportsA Rare Case of Erythema Gyratum Repens Associated With Esophageal Carcinoma.
CureusTargeted Therapies in Advanced Gastric Cancer.
Current treatment options in oncologyNewly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus.
Surgery todayDifferent response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1.
Future oncology (London, England)Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus.
Annals of surgical oncologyAn Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.
The oncologistCervical squamous cell carcinoma coexisting with ectopic gastric mucosa treated by endoscopic submucosal dissection: A case report.
Molecular and clinical oncologyA Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare.
Dermatology (Basel, Switzerland)Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.
Acta oncologica (Stockholm, Sweden)Acute treatment-related toxicity in elderly patients with good performance status compared to young patients in locally advanced esophageal carcinoma treated by definitive chemoradiation: A retrospective comparative study.
Journal of cancer research and therapeuticsLong-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.
Surgical endoscopy[Squamous cell carcinoma of the esophagus-two-field or three-field lymphadenectomy?].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen MedizenHemorrhagic Shock Secondary to Aortoesophageal Fistula as a Complication of Esophageal Cancer.
CureusDefinitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease.
Journal of radiation research[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen MedizenIsolated tumor cells in the regional lymph nodes in patients with squamous cell carcinoma of the esophagus are rarely observed but often represent part of a true metastasis.
Annals of diagnostic pathologyAnesthetic Management for Squamous Cell Carcinoma of the Esophagus.
Methods in molecular biology (Clifton, N.J.)Roundabout1 distribution in neoplastic and non-neoplastic diseases with a focus on neoangiogenesis.
International journal of clinical and experimental pathologyLong-term complete response in supraclavicular lymph node metastases of esophageal cancer using systemic chemotherapy-a case report.
International journal of clinical and experimental pathologyCost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.
Cancer medicineMultiple primary cancers in patients treated for squamous cell carcinoma of the esophagus.
Polski przeglad chirurgicznyOptimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Annals of surgical oncologyEarly administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study.
Cancer scienceThe Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis.
The American surgeonA Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome.
ACG case reports journalModified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.
Annals of surgical oncologyComparison of the therapeutic effects of endoscopic submucosal dissection and minimally invasive esophagectomy for T1 stage esophageal carcinoma.
Thoracic cancerEsophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation.
International journal of clinical oncology[Successful Multidisciplinary Treatment Accomplished by Collaboration of Multiple Clinical Departments for Synchronous Quadruple Cancer].
Kyobu geka. The Japanese journal of thoracic surgeryAssociation between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.
Esophagus : official journal of the Japan Esophageal SocietyDoes a Lymph Node-Based Model Predict Clinical Value for Adjuvant Therapy in Squamous Cell Carcinoma of the Esophagus Treated With Upfront Surgery?
Annals of surgical oncologyUncommon Endoscopic Findings in a Tylosis Patient: A Case Report.
Case reports in oncologyEndoscopic features and associated histology of an basaloid squamous cell carcinoma of the esophagus at the very early stage.
BMC cancerEvolving screening and surveillance techniques for Barrett's esophagus.
World journal of gastroenterologyEndoscopic resection for early esophageal carcinoma.
Journal of thoracic diseaseAcute Dysphagia Caused by Sarcomatoid Squamous Cell Carcinoma of the Esophagus.
CureusNeoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus.
Radiation oncology (London, England)Successful definitive concurrent chemoradiotherapy in a patient with esophageal cancer and Child-Pugh B cirrhosis of the liver.
Journal of cancer research and therapeuticsAssociation of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus.
IUBMB lifeInterpreting the Survival Benefit From Neoadjuvant Chemoradiotherapy Before Surgery for Locally Advanced Squamous Cell Carcinoma of the Esophagus.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyBronchoscopic cryosurgery for metastatic tumor causing central airway obstruction: A case report.
MedicineNovel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus.
Journal of gastrointestinal oncologyTriplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results.
OncotargetKEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.
Future oncology (London, England)Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction-A systematic review.
Pathology, research and practiceRadiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.
The Journal of surgical researchEffect of STAT3 decoy oligodeoxynucleotides mediated by ultrasound-targeted microbubbles combined with ultrasound on the growth of squamous cell carcinoma of the esophagus.
Oncology lettersNeoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus: the (NEOCRTEC5010) trial-a timely and welcome clinical trial from the Far East.
Journal of thoracic disease[Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and resection for squamous cell carcinoma of the esophagus].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen MedizenEfficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.
JAMA oncologyPATHOLOGIC COMPLETE RESPONSE (YPT0 YPN0) AFTER CHEMOTHERAPY AND RADIOTHERAPY NEOADJUVANT FOLLOWED BY ESOPHAGECTOMY IN THE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS.
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgeryUse of curcumin solution for probe-based confocal laser endomicroscopy of squamous cell carcinoma of the esophagus.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy SocietyExpression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.
Oncology lettersCancers Due to Smoking and High Alcohol Consumption.
Deutsches Arzteblatt internationalEffects of Spinal-Z in Patients with Gastroesophageal Cancer.
Journal of pharmacopunctureEndoscopic or Surgical Resection for Gastro-Esophageal Cancer.
Deutsches Arzteblatt internationalNeoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical OncologyComparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
Radiation oncology (London, England)Synchronous triple squamous cell carcinoma of the esophagus.
International journal of surgery case reportsEsophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography during neoadjuvant therapy.
Surgical case reportsRefractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.
Journal of gastrointestinal cancerThe Clinical Implications of Death Domain-Associated Protein (DAXX) Expression.
The Korean journal of thoracic and cardiovascular surgeryPhase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.
OncologyEffects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
Anesthesia and analgesiaEndovascular Treatment of Carotid Blowout Syndrome.
Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e VascularMicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.
Journal of translational medicineA genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years.
PharmacogenomicsThe Infection Returns: A Case of Pulmonary Sporotrichosis Relapse after Chemotherapy.
Case reports in medicineEndoscopic submucosal tunnel dissection for early squamous cell carcinoma of the esophagus.
EndoscopyStereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report.
Molecular and clinical oncologyExtranodal extension of nodal metastasis is the main prognostic moderator in squamous cell carcinoma of the esophagus after neoadjuvant chemoradiotherapy.
Journal of thoracic diseaseAn analysis of the risk factors of anastomotic stricture after esophagectomy.
Surgery todayComparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
Radiation oncology (London, England)Endoscopic submucosal dissection of a squamous cell carcinoma of the esophagus developing in the area of a previous Heller's myotomy for achalasia.
EndoscopyOverall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World.
Advances in therapyComparative Analysis of Clinical, Treatment, and Survival Characteristics of Basaloid and Squamous Cell Carcinoma of the Esophagus.
Journal of the American College of SurgeonsWith or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyIdentification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus.
Oncology lettersSubcutaneous metastasis from recurrent basaloid squamous cell carcinoma of the esophagus.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersContinuous intraoperative vagus nerve stimulation for monitoring of recurrent laryngeal nerve during minimally invasive esophagectomy.
Journal of visualized surgeryCYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusA Case of Basaloid Squamous Cell Carcinoma of Polypoid Type in the Esophagus.
Case reports in gastroenterologyThe importance of the concept and histological criteria of "intraepithelial squamous cell carcinoma" of the esophagus: in comparison between Western and Japanese criteria.
Esophagus : official journal of the Japan Esophageal SocietyCombination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus.
OncotargetA phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
BMC cancerTreatment of Squamous Cell Carcinoma of the Esophagus Synchronously Associated with Head and Neck Cancer.
In vivo (Athens, Greece)Clinicopahological features of superficial basaloid squamous cell carcinoma of the esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusPrevalence of Squamous Cell Carcinoma of the Esophagus in a Single Tertiary Center of South Africa: A Cross Sectional Analytic Study.
Journal of public health in AfricaThe Significance of SCC and CEA mRNA in the Pleural Cavity After Lymphadenectomy in Esophageal Cancer Patients who Underwent Preoperative Treatment.
World journal of surgerySOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncA long-term survival case after surgical resection of skeletal muscle metastasis following esophagectomy for squamous cell carcinoma of the esophagus.
Journal of surgical case reportsRacial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.
PloS oneCurrent trends in multimodality treatment of esophageal and gastroesophageal junction cancer - Review article.
Surgical oncologyDVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.
Radiation oncology (London, England)Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.
Molecular and clinical oncologyEndoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.
GastroenterologyFibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques.
European journal of histochemistry : EJHA novel gene expression scoring system for accurate diagnosis of basaloid squamous cell carcinoma of the esophagus.
International journal of oncologySquamous Cell Carcinoma of Oesophagus with Tracheo- Esophageal Fistula, Pulmonary Tuberculosis and Hyperthyroidism in 16 yrs Old Female.
The Journal of the Association of Physicians of IndiaAn isolated unusual digit metastasis from esophageal carcinoma: a case report.
OncoTargets and therapySevere neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus.
Clinical case reportsGlycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus.
World journal of surgeryEndoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer.
Annals of cardiothoracic surgeryHigh dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Thoracic cancerBilateral approach for thoracoscopic esophagectomy with lymph node dissection in the dorsal area of the thoracic aorta in patients with esophageal cancer: A report of two cases.
International journal of surgery case reportsSystemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.
MedicineAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Carcinoma de células escamosas esofágicas.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Carcinoma de células escamosas esofágicas e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
É um tipo de tumor maligno do esôfago que se localiza mais frequentemente nos terços superior ou médio do órgão. É identificado na literatura médica pelas siglas CEC ou ESCC e catalogado sob o código CID-10 C15.4.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
6 publicações do grafo RarasNet (PubMed) · 5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Carcinoma de células escamosas esofágicas. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/carcinoma-de-celulas-escamosas-esofagicas
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Carcinoma de células escamosas esofágicas
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Codificação WHO/SUS
- fonte: WHO ICD-10 / DATASUS
- CID-11 (futuro)
- fonte: WHO ICD-11
- NIH/GARD
- fonte: GARD (NIH)
- Indexação biomédica
- fonte: MeSH (NLM)
- Dado público estruturado
- fonte: Wikidata
- Medicamentos aprovados FDA
- fonte: FDA OpenFDA
- Reposicionamento
- fonte: Drug Repurposing Hub
- Ensaios clínicos
- fonte: ClinicalTrials.gov